The historic rise of Viagra has consistently remained a example of pharmaceutical success, yet its position within the broader sector now triggers questions about future gains. Generic versions are undercutting patent protection , prompting anxieties that investing in companies significantly dependent to Viagra's once-dominant influence could be a